{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:23Z","timestamp":1793407583966,"version":"4.5.0"},"reference-count":64,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018940","name":"The Danish Diabetes Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018940","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novo Nordisk A\/S"},{"name":"The Danish Heart Association"},{"name":"AstraZeneca A\/S"},{"name":"The Danish Regions"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,26]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) risk remains high but unevenly distributed in patients with type 2 diabetes mellitus (T2DM). Current risk stratification strategies are far from optimal, leading to both undertreatment and overtreatment of patients. The STENO INTEN-CT trial aims to evaluate a strategy of improved CVD risk management by using cardiac CT (coronary artery calcification (CAC)) for stratification and tailoring of multifactorial cardiovascular treatment based on CAC score. We hypothesise that (1) intensified medical treatment will lower CVD event rates in high-risk patients (CAC\u2265100), and (2) less intensive multifactorial treatment is safe in very low-risk patients (CAC=0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Steno INTEN-CT trial is an investigator-initiated, pragmatic, open-label, event-driven randomised controlled trial including patients with T2DM without known CVD. All participants (expected n=7300) will be invited for a non-contrast coronary CT scan. After the scan, participants will be randomised to either standard treatment (blinded for CAC results) or CAC-based treatment. Participants in CAC-based treatment and their general practitioner (GP) will receive information on CAC and a recommendation of multifactorial treatment. High-risk participants in the interventional arm will be invited for one or more initial study visits to intensify treatment with a combination of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, high-dose lipid-lowering, antihypertensive and antithrombotic treatment. Very low-risk patients in the interventional arm will be recommended less intensive treatment targets. After initial study-related activities, all participants will continue to be taken care of by their GP guided by specific treatment recommendations. The primary outcome in the primary hierarchical analysis (the rate of the combined CVD endpoint of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke and hospitalisation for heart failure) will be monitored through national health registries. The trial is event-driven, but a median follow-up of 5 years is expected. Key secondary outcomes include patient-reported outcomes, quality-adjusted life years and healthcare costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      The protocol V.1.9 is approved by the Research Ethics Committee and the Danish Medicines Agency and the Danish Data Protection Agency. The results of the study\u2014positive, negative or neutral\u2014will be published in peer-reviewed journals and through\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\">www.clinicaltrials.org<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05700877\">NCT05700877<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-106018","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:30:12Z","timestamp":1765863012000},"page":"e106018","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05700877","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-5550","authenticated-orcid":false,"given":"Kristian L\u00f8kke","family":"Funck","sequence":"first","affiliation":[{"name":"Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2702-0231","authenticated-orcid":false,"given":"Britt","family":"Borregaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Egstrup","sequence":"additional","affiliation":[{"name":"Cardiovascular Center of Excellence Southern DK, Svendborg Sygehus, Svendborg, Syddanmark, Denmark"},{"name":"Steno Diabetes Center Odense, Odense University Hospital, Odense, Region Syddanmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskild Klausen","family":"Fredslund","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Willum","family":"Hansen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Capital Region of Denmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Kallestrup","sequence":"additional","affiliation":[{"name":"Research Unit of General Practice, Department of Public Health, Aarhus Universitet, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hecht","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Steno Diabetes Center Zealand, Holbaek Hospital, Holb\u00e6k, Region Zealand, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Capital Region of Denmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-142X","authenticated-orcid":false,"given":"Susanne","family":"Reventlow","sequence":"additional","affiliation":[{"name":"Department of Public Health, Copenhagen University Section of General Practice, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Capital Region of Denmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelli","family":"Sandb\u00e6k","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1629-1864","authenticated-orcid":false,"given":"Jens","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Research Unit of General Practice, University of Southern Denmark, Odense, Region Syddanmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus Laust","family":"Thomsen","sequence":"additional","affiliation":[{"name":"Center for General Practice, Aalborg University, Aalborg, North Denmark Region, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-2967","authenticated-orcid":false,"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, North Denmark Region, Denmark"},{"name":"Aalborg Universitet, Aalborg, North Denmark Region, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per L\u00f8gstrup","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-4826","authenticated-orcid":false,"given":"Axel","family":"Diederichsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Odense University Hospital, Odense, Denmark"},{"name":"Steno Diabetes Center Odense, Odense University Hospital, Odense, Region Syddanmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026011304100482000_15.12.e106018.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.063374"},{"key":"2026011304100482000_15.12.e106018.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1358"},{"key":"2026011304100482000_15.12.e106018.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01494.x"},{"key":"2026011304100482000_15.12.e106018.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1454-0"},{"key":"2026011304100482000_15.12.e106018.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad260"},{"key":"2026011304100482000_15.12.e106018.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"2026011304100482000_15.12.e106018.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032038"},{"key":"2026011304100482000_15.12.e106018.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"2026011304100482000_15.12.e106018.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"2026011304100482000_15.12.e106018.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"2026011304100482000_15.12.e106018.11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"The Lancet"},{"key":"2026011304100482000_15.12.e106018.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347"},{"key":"2026011304100482000_15.12.e106018.13","unstructured":"Definition, diagnosis and classification of diabetes mellitus and its complications - report of a who consultation."},{"key":"2026011304100482000_15.12.e106018.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2016.10.002"},{"key":"2026011304100482000_15.12.e106018.15","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"2026011304100482000_15.12.e106018.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2005.00438.x"},{"key":"2026011304100482000_15.12.e106018.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2004.00269.x"},{"key":"2026011304100482000_15.12.e106018.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"2026011304100482000_15.12.e106018.19","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqt161"},{"key":"2026011304100482000_15.12.e106018.20","unstructured":"M.F. Drummond MJS , Claxton K , Stoddart GL , et al . Methods for the Economic Evaluation of Health Care Programmes. Oxford Oxford University Press, 2015."},{"key":"2026011304100482000_15.12.e106018.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.10.008"},{"key":"2026011304100482000_15.12.e106018.22","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-021-00639-3"},{"key":"2026011304100482000_15.12.e106018.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208681"},{"key":"2026011304100482000_15.12.e106018.24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/CLEP.S246636","article-title":"Feasibility Study of Advanced Cardiovascular Screening in Middle-Aged Patients with Diabetes","volume":"12","author":"Lindholt","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2026011304100482000_15.12.e106018.25","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/eurheartj\/ehz913","article-title":"Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?","volume":"41","author":"Malmborg","year":"2020","journal-title":"Eur Heart J"},{"key":"2026011304100482000_15.12.e106018.26","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12231"},{"key":"2026011304100482000_15.12.e106018.27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/hex.13228","article-title":"Involving people with type 2 diabetes in facilitating participation in a cardiovascular screening programme","volume":"24","author":"Dahl","year":"2021","journal-title":"Health Expect"},{"key":"2026011304100482000_15.12.e106018.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.12.023"},{"key":"2026011304100482000_15.12.e106018.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390404"},{"key":"2026011304100482000_15.12.e106018.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.720847"},{"key":"2026011304100482000_15.12.e106018.31","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/ehjci\/jez010","article-title":"Risk stratification by assessment of coronary artery disease using coronary computed tomography angiography in diabetes and non-diabetes patients: a study from the Western Denmark Cardiac Computed Tomography Registry","volume":"20","author":"Olesen","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026011304100482000_15.12.e106018.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800256"},{"key":"2026011304100482000_15.12.e106018.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.2.180"},{"key":"2026011304100482000_15.12.e106018.34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rec.2022.04.003","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"75","author":"Visseren","year":"2022","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2026011304100482000_15.12.e106018.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192278"},{"key":"2026011304100482000_15.12.e106018.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4242"},{"key":"2026011304100482000_15.12.e106018.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.05.027"},{"key":"2026011304100482000_15.12.e106018.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-021-02352-4","article-title":"Value of addition of coronary artery calcium to risk scores in the prediction of major cardiovascular events in patients with type 2 diabetes","volume":"21","author":"Zafrir","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2026011304100482000_15.12.e106018.39","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn279"},{"key":"2026011304100482000_15.12.e106018.40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003528","article-title":"Absence of Coronary Artery Calcium Identifies Asymptomatic Diabetic Individuals at Low Near-Term But Not Long-Term Risk of Mortality: A 15-Year Follow-Up Study of 9715 Patients","volume":"9","author":"Valenti","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026011304100482000_15.12.e106018.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.09.068"},{"key":"2026011304100482000_15.12.e106018.42","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0816"},{"key":"2026011304100482000_15.12.e106018.43","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1548"},{"key":"2026011304100482000_15.12.e106018.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108237"},{"key":"2026011304100482000_15.12.e106018.45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijcard.2017.01.132","article-title":"Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis","volume":"236","author":"Chaikriangkrai","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026011304100482000_15.12.e106018.46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/dc21-1607","article-title":"Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis","volume":"45","author":"Ferket","year":"2022","journal-title":"Diabetes Care"},{"key":"2026011304100482000_15.12.e106018.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.11.028"},{"key":"2026011304100482000_15.12.e106018.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.01.040"},{"key":"2026011304100482000_15.12.e106018.49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021778"},{"key":"2026011304100482000_15.12.e106018.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60698-3"},{"key":"2026011304100482000_15.12.e106018.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1212914"},{"key":"2026011304100482000_15.12.e106018.52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","volume":"5","author":"Ueki","year":"2017","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"2026011304100482000_15.12.e106018.53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057934"},{"key":"2026011304100482000_15.12.e106018.54","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41591-024-03133-0","article-title":"Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial","volume":"30","author":"Mann","year":"2024","journal-title":"Nat Med"},{"key":"2026011304100482000_15.12.e106018.55","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05787-2"},{"key":"2026011304100482000_15.12.e106018.56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192"},{"key":"2026011304100482000_15.12.e106018.57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18\u2008686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Cholesterol Treatment Trialists","year":"2008","journal-title":"The Lancet"},{"key":"2026011304100482000_15.12.e106018.58","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz486"},{"key":"2026011304100482000_15.12.e106018.59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S2213-8587(17)30313-3","article-title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","volume":"5","author":"Sabatine","year":"2017","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"2026011304100482000_15.12.e106018.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2017.12.006"},{"key":"2026011304100482000_15.12.e106018.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"2026011304100482000_15.12.e106018.62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"2026011304100482000_15.12.e106018.63","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/ehjci\/jey014","article-title":"Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials","volume":"19","author":"Clerc","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026011304100482000_15.12.e106018.64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15825"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-106018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:10:16Z","timestamp":1768306216000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-106018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,15]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-106018"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-106018","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}